Less is more: artificial intelligence and gene-expression arrays. by Hamdy, F, Catto, J

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit. by Catto, J, Hamdy, F

The role of genetic instability in the pathogenesis and progression of urothelial carcinoma by Catto, J, Hamdy, F

Haematuria by Bryant, R, Catto, J

Reply from Authors re: David J. DeGraff. Novel Use of a Combined Artificial Intelligence Approach to Identify Patients with Noninvasive Urothelial Cell Carcinoma of the Urinary Bla... by Catto, J, Hamdy, F

Genetic instability and transitional cell carcinoma of the bladder. by Catto, J, Meuth, M, Hamdy, F

Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression. by Catto, J, Abbod, M, Linkens, D, Hamdy, F

Predictive modeling in cancer: where systems biology meets the stock market. by Abbod, M, Hamdy, F, Linkens, D, Catto, J

Comparative study of intelligent models for the prediction of bladder cancer progression. by Abbod, M, Linkens, D, Catto, J, Hamdy, F

The use of proteomics in urological research by Rehman, I, Azzouzi, A, Catto, J, Hamdy, F

URINARY MICRORNA IN BLADDER CANCER - A POTENTIAL DIAGNOSTIC TOOL by Miah, S, Dudziec, E, Rosario, D, Hamdy, F, Catto, J

In defense of randomized clinical trials in surgery: Let us not forget Archie Cochrane's legacy. by Catto, J, Blazeby, J, Holmberg, L, Hamdy, F, Brown, J

Hypoxia regulated miRNAs in bladder cancer by Blick, C, Ramachandran, A, Cranston, D, Catto, J, Harris, A

Artificial intelligence for the prediction bladder cancer by Abbod, M, Catto, J, Chen, M, Linkens, D, Hamdy, F

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target by Catto, J, Rehman, I, Dhawan, D, Meuth, M, Hamdy, F

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. by Catto, J, Xinarianos, G, Burton, J, Meuth, M, Hamdy, F

Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A. by Leiblich, A, Cross, S, Catto, J, Pesce, G, Hamdy, F, Rehman, I

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls. by Yates, DR, Rehman, I, Meuth, M, Cross, S, Hamdy, F, Catto, J

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder by Yates, DR, Rehman, I, Meuth, M, Cross, S, Hamdy, F, Catto, J

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients by Yates, DR, Catto, J, Rehman, I, Meuth, M, Cross, S, Hamdy, F